Discontinued — last reported Q1 '18
DexCom Trading securities, cost increased by 0.7% to $219.50M in Q1 2026 compared to the prior quarter.
other_equity_securities_without_readily_determinable_fai_3fb207| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $218.00M | $219.50M |
| QoQ Change | — | +0.7% |